1. Home
  2. OTH vs NSPR Comparison

OTH vs NSPR Comparison

Compare OTH & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OTH

Off The Hook YS Inc.

N/A

Current Price

$2.64

Market Cap

67.2M

Sector

Industrials

ML Signal

N/A

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.59

Market Cap

67.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTH
NSPR
Founded
2012
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.2M
67.4M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
OTH
NSPR
Price
$2.64
$1.59
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
74.0K
41.8K
Earning Date
12-15-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$112,361,879.00
$7,779,000.00
Revenue This Year
N/A
$22.76
Revenue Next Year
N/A
$75.45
P/E Ratio
$654.51
N/A
Revenue Growth
22.35
14.04
52 Week Low
$1.95
$1.51
52 Week High
$3.90
$3.80

Technical Indicators

Market Signals
Indicator
OTH
NSPR
Relative Strength Index (RSI) N/A 34.22
Support Level N/A $1.51
Resistance Level N/A $1.66
Average True Range (ATR) 0.00 0.14
MACD 0.00 -0.03
Stochastic Oscillator 0.00 10.94

Price Performance

Historical Comparison
OTH
NSPR

About OTH Off The Hook YS Inc.

Off The Hook YS Inc operates as a nationwide leader in the yacht and boat dealership industry, offering a comprehensive suite of services that spans the entire boat value chain. The company operates as two segments: Boat Sales and Azure Funding. Boat Sales includes Specializing in the buying, selling, and wholesaling of yachts and boats, having a boat dealership created to run Yellow Fin sales in Miami; and Azure Funding includes a recreational loan broker and lender providing financing solutions for individuals, dealerships, and brokerages.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: